The Cohen Syndrome Research Foundation (CSRF) is pleased to announce the release of our new Request for Applications (RFA) focused on advancing research into VPS13B (Cohen Syndrome). This RFA was developed with extensive input from our recent Research Roundtable and reflects the collective priorities of leading scientists, clinicians, and advocates in the field.
CSRF invites Letters of Intent for innovative projects spanning model development, VPS13B protein function, biomarker discovery, and therapeutic and drug-delivery strategies. Together, these efforts aim to accelerate translational progress and lay the groundwork for meaningful therapies for individuals living with Cohen Syndrome.
Letter of Intent Deadline: January 16, 2026
Full Application Deadline: April 3, 2026